At the time of writing, Praxis Precision Medicines Inc [PRAX] stock is trading at $270.98, up 9.27%. An important factor to consider is whether the stock is rising or falling in short-term value. The PRAX shares have gain 46.82% over the last week, with a monthly amount glided 57.23%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Praxis Precision Medicines Inc [NASDAQ: PRAX] stock has seen the most recent analyst activity on November 19, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $424. On May 07, 2025, Chardan Capital Markets initiated with a Buy rating and assigned a price target of $80 on the stock. H.C. Wainwright reiterated its Buy rating and decreased its price target to $105 on March 03, 2025. Deutsche Bank initiated its recommendation with a Buy and recommended $111 as its price target on February 11, 2025. Oppenheimer started tracking with a Outperform rating for this stock on August 05, 2024, and assigned it a price target of $134. In a note dated June 24, 2024, Needham initiated an Buy rating and provided a target price of $145 on this stock.
For the past year, the stock price of Praxis Precision Medicines Inc fluctuated between $26.70 and $277.44. Currently, Wall Street analysts expect the stock to reach $366.8 within the next 12 months. Praxis Precision Medicines Inc [NASDAQ: PRAX] shares were valued at $270.98 at the most recent close of the market. An investor can expect a potential return of 35.36% based on the average PRAX price forecast.
Analyzing the PRAX fundamentals
According to Praxis Precision Medicines Inc [NASDAQ:PRAX], the company’s sales were 7.46M for trailing twelve months, which represents an -100.00% plunge. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -34.98%, Pretax Profit Margin comes in at -32.33%, and Net Profit Margin reading is -32.33%. To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.6 and Total Capital is -0.67. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 259.13 points at the first support level, and at 247.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 280.42, and for the 2nd resistance point, it is at 289.85.
Ratios To Look Out For
It is important to note that Praxis Precision Medicines Inc [NASDAQ:PRAX] has a current ratio of 5.18. On the other hand, the Quick Ratio is 5.18, and the Cash Ratio is 3.24. Considering the valuation of this stock, the price to sales ratio is 908.37, the price to book ratio is 16.70.
Transactions by insiders
Recent insider trading involved Nemiroff Alex, General Counsel and Secretary, that happened on Nov 20 ’25 when 25130.0 shares were sold. Principal Accounting Officer, Mastrocola Lauren completed a deal on Nov 20 ’25 to sell 13600.0 shares. Meanwhile, Officer Nemiroff Alex bought 25130.0 shares on Nov 20 ’25.
